title: Expert consensus on the treatment of hypertension with chinese patent medicines.
abstract: Objectives. This study was aimed to determine the therapeutic principle and identify Chinese Patent Medicine (CPM) with corresponding indications for hypertension treatment. Methods. Three rounds of Delphi survey were mailed among 40 cardiovascular integrative medicine specialists. Items with agreement of more than 80% respondents were included in the consensus. Results. According to majority of the panelists, CPM is suitable for most hypertensive patients and should be used according to traditional Chinese medicine pattern classification. CPM could be used alone for grade 1 hypertension and could be used in combination with Western biomedicine (WM) for both grade 2 and grade 3 hypertension. It is recommended that less than two CPMs are used simultaneously. For the treatment of grade 2 and 3 hypertension, CPM and WM should be taken separately. Recommended CPMs included Tianma Gouteng granule, Qiju Dihuang capsule, Jinkui Shenqi pill, Yinxingye tablet, Niuhuang Jiangya pill and Banxia Tianma pill. The indications of 4 CPMs were specified with symptoms related to TCM pattern classification by the experts. Conclusions. An expert consensus on CMP application was formed for the treatment of hypertension in the form of integrative medicine. A flow of IM hypertension management was proposed based on the results of the survey.
authors: Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
authors: Li Ying
authors: LY
authors: Wang
authors: Kam Wa
authors: KW
authors: Chan
authors: Ya
authors: Y
authors: Yuwen
authors: Nan Nan
authors: NN
authors: Shi
authors: Xue Jie
authors: XJ
authors: Han
authors: Aiping
authors: A
authors: Lu
references: Circulation. 2001 Nov 27;104(22):2746-53
references: 11723030
references: J Hypertens. 2003 Nov;21(11):1983-92
references: 14597836
references: Guang Pu Xue Yu Guang Pu Fen Xi. 1999 Jun;19(3):417-8
references: 15819077
references: Asia Pac J Clin Nutr. 2001;10(2):76-80
references: 11710361
references: Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004 Jun;24(6):553-5
references: 15250215
references: J Public Health Med. 1998 Dec;20(4):441-8
references: 9923952
references: Biomed Environ Sci. 2012 Jun;25(3):251-6
references: 22840574
references: Public Health Nutr. 2002 Feb;5(1A):239-43
references: 12027290
references: Hypertension. 2002 Dec;40(6):920-7
references: 12468580
references: Zhongguo Zhong Yao Za Zhi. 2005 Apr;30(8):606-9
references: 16011287
references: J Hum Hypertens. 2000 Oct-Nov;14(10-11):749-63
references: 11095165
references: Ann Intern Med. 2001 Jan 2;134(1):1-11
references: 11187414